Final ProgramCPSA 2012
Transforming Drug Discovery & Development Through Innovation:
Past, Present and Future
October 1 - 4, 2012
Sheraton Bucks County Hotel
Langhorne, PA
Session Synopsis
Monday, 10:00 am - 11:30 am
Small Molecule Biomarkers
Discussion Leader: Petia Shipkova, Bristol-Myers Squibb
Biomarkers have become essential tools in assessing drug efficacy and safety evaluation as well as disease diagnosis. Discovery of new biomarkers as well as development of assays for their measurement is an area of increasing interest. This session will focus on recent developments in discovery and application of biomarkers.
Presentations:
Application of LC/MS Biomarker Assays in Drug Discovery
Joelle Onorato, Bristol-Myers Squibb
Measuring the Dynamics of Low Abundant Proteins: Clinical Studies
Michael Lassman, Merck
Chemoplexing: Another Step Toward the Digitization of Biology
Rick King, PharmaCadence
Return to program